TREM2 ‐dependent microglial function is essential for remyelination and subsequent neuroprotection
Glia · 2023-05 · 71 (5) · 1247-1258
DOI: 10.1002/glia.24335 ↗Kurz gefasst
Fachartikel in der Zeitschrift Glia, online erschienen am 10.01.2023. Verfasst von Yuanyuan Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Genentech Inc., South San Francisco, California, USA. Hauptthemen laut MEDLINE: Remyelination, Multiple Sclerosis. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Disability in multiple sclerosis (MS) is driven in part by the failure of remyelination and progressive neurodegeneration. Microglia, and specifically triggering receptor expressed on myeloid cells 2 (TREM2), a factor highly expressed in microglia, have been shown to play an important role in remyelination. Here, using a focal demyelination model in the brain, we demonstrate that demyelination is persistent in TREM2 knockout mice, lasting more than 6 weeks after lysolecithin injection and resulting in substantial neurodegeneration. We also find that TREM2 knockout mice exhibit an altered glial response following demyelination. TREM2 knockout microglia demonstrate defects in migration and phagocytosis of myelin debris. In addition, human monocyte‐derived macrophages from subjects with a TREM2 mutation prevalent in human disease also show a defect in myelin debris phagocytosis. Together, we highlight the central role of TREM2 signaling in remyelination and neuroprotection. These findings provide insights into how chronic demyelination might lead to axonal damage and could help identify novel neuroprotective therapeutic targets for MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Genentech Inc., South San Francisco, California, USA.
- Department of Biomedical Imaging, Genentech Inc., South San Francisco, California, USA.
- Department of Pathology, Genentech Inc., South San Francisco, California, USA.
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
ORCID-Profile: Tracy J Yuen
Zitieren
APA
Wang, Y., Kyauk, R. V., Shen, Y. A., Xie, L., Reichelt, M., Lin, H., Jiang, Z., Ngu, H., Shen, K., Greene, J. J., Sheng, M., & Yuen, T. J. (2023). TREM2 ‐dependent microglial function is essential for remyelination and subsequent neuroprotection. Glia, 71(5), 1247-1258. https://doi.org/10.1002/glia.24335
Vancouver
Wang Y, Kyauk RV, Shen YA, Xie L, Reichelt M, Lin H, et al. TREM2 ‐dependent microglial function is essential for remyelination and subsequent neuroprotection. Glia. 2023;71(5):1247-1258. doi:10.1002/glia.24335
BibTeX
@article{Wang2023,
author = {Wang, Yuanyuan and Kyauk, Roxanne V and Shen, Yun-An A and Xie, Luke and Reichelt, Mike and Lin, Han and Jiang, Zhiyu and Ngu, Hai and Shen, Kimberle and Greene, Jacob J and Sheng, Morgan and Yuen, Tracy J},
title = {TREM2 ‐dependent microglial function is essential for remyelination and subsequent neuroprotection},
journal = {Glia},
year = {2023},
volume = {71},
number = {5},
pages = {1247--1258},
doi = {10.1002/glia.24335}
}
EUVIMED